| Literature DB >> 31214555 |
Donghwa Yang1, Eell Ryoo1, Hyo Jeong Kim1.
Abstract
Purpose: Predicting neurologic prognosis in pediatric patients recovered after cardiac arrest is more difficult than in adults. This study hypothesized that a combination model of early electroencephalography, brain computed tomography (CT), and laboratory findings improve prediction performance of neurologic outcome in pediatric patients after cardiac arrest.Entities:
Keywords: ammonia; cardiac arrest; electroencephalography; gray matter to white matter attenuation ratio; neurologic outcome; pediatric
Year: 2019 PMID: 31214555 PMCID: PMC6558142 DOI: 10.3389/fped.2019.00223
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Figure 1EEG background scoring. (A) Score 0: normal/organized pattern (B) Score 1: slow and disorganized pattern (C) Score 2: discontinuous or burst suppression pattern (D) Score 3: suppressed and featureless pattern. EEG, electroencephalography.
Clinical characteristics and neurologic outcomes.
| Age in years, median (IQR) | 0.5 (0.3–12.0) | 1.2 (0.3–9.1) | 0.88 |
| Male sex, | 6 (85.7) | 8 (57.1) | 0.34 |
| Arrest duration in minutes, mean ± SD | 11.4 ± 9.3 | 18.1 ± 9.0 | 0.13 |
| Arrest etiology, | 1.00 | ||
| Asphyxia/Respiratory | 5 (71.4) | 9 (64.3) | 1.00 |
| Cardiac | 0 | 1 (7.1) | 1.00 |
| Near drowning | 0 | 1 (7.1) | 1.00 |
| Others | 2 (28.6) | 3 (21.4) | 1.00 |
| Preexisting conditions, | 0.54 | ||
| None | 4 (57.1) | 10 (71.4) | 0.64 |
| Neurologic | 0 | 2 (14.3) | 0.53 |
| Cardiac | 1 (14.3) | 1 (7.1) | 1.00 |
| Other | 2 (28.6) | 1 (7.1) | 0.25 |
| Initial cardiac rhythm, | 1.00 | ||
| PEA | 1 (14.3) | 2 (14.3) | 1.00 |
| V fib/Tachycardia | 0 | 1 (7.1) | 1.00 |
| Asystole | 6 (85.7) | 11 (78.6) | 1.00 |
| Hypothermia treatment, | 3 (42.9) | 6 (42.9) | 1.00 |
| ROSC to EEG onset, | 0.85 | ||
| < 24 h | 3 (42.9) | 7 (50.0) | 1.00 |
| Between 24 and ≤ 48 h | 3 (42.9) | 4 (28.6) | 0.64 |
| Between 48 and ≤ 72 h | 1 (14.3) | 3 (21.4) | 1.00 |
| Medication during EEG recording, | |||
| Sedative drug | 0.34 | ||
| Fentanyl | 1 (14.3) | 1 (7.1) | 1.00 |
| Remifentanil | 1 (14.3) | 3 (21.4) | 1.00 |
| Midazolam | 4 (57.1) | 4 (28.6) | 0.35 |
| Muscle relaxant | 0.62 | ||
| Vecuronium | 0 | 2 (14.3) | 0.53 |
| Rocuronium | 1 (14.3) | 2 (14.3) | 1.00 |
| Antiepileptic drug | 0.35 | ||
| Phenobarbital | 3 (42.9) | 2 (14.3) | 0.28 |
| Phenytoin | 2 (28.6) | 2 (14.3) | 0.57 |
| Valproic acid | 1 (14.3) | 1 (7.1) | 1.00 |
IQR, interquartile ranges; SD, standard deviation; ROSC, return of spontaneous circulation; EEG, electroencephalography; PEA, pulseless electrical activity; V fib, ventricular fibrillation.
EEG findings and neurologic outcomes.
| EEG background score, | 0.006 | ||
| Score 0 (normal/organized) | 0 | 0 | NA |
| Score 1 (slow and disorganized) | 5 (71.4) | 1 (7.1) | 0.006 |
| Score 2 (discontinuous or burst suppression) | 0 | 0 | NA |
| Score 3 (suppressed and featureless) | 2 (28.6) | 13 (92.9) | 0.006 |
| Reactivity, | 5 (71.4) | 1 (7.1) | 0.006 |
| Electrographic seizures, | 0.04 | ||
| None | 4 (57.1) | 12 (85.7) | 0.28 |
| Seizure | 3 (42.9) | 0 | 0.03 |
| Status epilepticus | 0 | 2 (14.3) | 0.53 |
EEG, electroencephalography; NA, not available.
Brain CT, laboratory findings, and neurologic outcomes.
| GWR in brain CT, mean ± SD | 1.20 ± 0.09 | 1.11 ± 0.07 | 0.03 |
| Laboratory findings, median (IQR) | |||
| S-100 (μg/L) ( | 1.0 (0.7–1.1) | 1.3 (0.8–1.9) | 0.19 |
| AST (U/L) ( | 70 (42–245) | 238 (128–337) | 0.08 |
| ALT (U/L) ( | 36 (19–218) | 143 (58–201) | 0.13 |
| pH ( | 7.13 (6.95–7.38) | 6.8 (6.8–6.85) | 0.006 |
| Lactate (mmol/L) ( | 4.4 (3.5–13.6) | 15.0 (11.8–15.0) | 0.006 |
| Ammonia (μg/dL) ( | 83 (68–268) | 422 (236–905) | 0.003 |
CT, computed tomography; GWR, gray matter to white matter attenuation ratio; SD, standard deviation; IQR, interquartile ranges; AST, aspartate transaminase; ALT, alanine transaminase.
Predictive values for neurologic outcome.
| EEG background score 0, 1 | Good | 0.821 (0.595–0.952) | 71.4 (29.0–96.3) | 92.9 (66.1–99.8) | 83.4 (41.6–97.3) | 86.7 (66.7–95.5) | 0.001 |
| EEG background score 2, 3 | Poor | 0.821 (0.595–0.952) | 71.4 (29.0–96.3) | 92.9 (66.1–99.8) | 83.4 (41.6–97.3) | 86.7 (66.7–95.5) | 0.001 |
| Reactivity | Good | 0.821 (0.595–0.952) | 71.4 (29.0–96.3) | 92.9 (66.1–99.8) | 83.4 (41.6–97.3) | 86.7 (66.7–95.5) | 0.001 |
| Electrographic seizures | Good | 0.714 (0.478–0.887) | 42.9 (9.9–81.6) | 100 (76.8–100) | 100 | 77.8 (64.9–87.0) | 0.03 |
| Brain CT GWR | Poor | 0.776 (0.543–0.926) | 71.4 (41.9–91.6) | 71.4 (29.0–96.3) | 83.3 (59.7–94.4) | 55.5 (32.5–76.3) | 0.01 |
| Ammonia | Poor | 0.888 (0.674–0.982) | 92.9 (66.1–9.8) | 71.4 (29.0–96.3) | 86.6 (66.6–95.5) | 83.5 (41.7–97.3) | <0.001 |
| EEG background 2, 3 + Ammonia | Poor | 0.929 (0.728–0.995) | 92.9 (66.1–99.8) | 85.7 (42.1–99.6) | 92.8 (67.8–98.8) | 85.8 (47.1–97.6) | <0.001 |
| EEG background 2, 3 + Brain CT GWR | Poor | 0.939 (0.742–0.997) | 92.9 (66.1–99.8) | 100 (59.0–100) | 100 | 87.6 (51.5–97.9) | <0.001 |
| EEG background 2, 3 + Brain CT GWR + Ammonia | Poor | 0.959 (0.772–0.999) | 92.9 (66.1–99.8) | 100 (59.0–100) | 100 | 87.6 (51.5–97.9) | <0.001 |
Data are expressed as value (95% confidence interval). AUC, area under the curve; PPV, positive predictive value; NPV, negative predictive value; EEG, electroencephalography; GWR, gray matter to white matter attenuation ratio.
Figure 2ROC curves to predict poor neurologic outcome. (A) AUC for single variable, EEG background score 2, 3: 0.821, GWR: 0.776, Ammonia: 0.888 (B) AUC for combination of EEG and Ammonia: 0.929, EEG and GWR: 0.939, EEG and GWR and Ammonia: 0.959. ROC, receiver operating characteristic; AUC, area under curve; EEG, electroencephalography; GWR, gray matter to white matter attenuation ratio; CI, confidence interval.